Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.1068 per EA under NDC 00527241541. Its NADAC has been published 119 times since Aug 10, 2022.
FDA first approved this application on Aug 21, 2017. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Lannett Company Inc.NDC
00527241541
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208652FDA Approved
8/21/2017
TE Code
AB3
On Market Since
1/8/2018
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 119 times since Aug 10, 2022, and over the history we have for it it has declined 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1068 per EA |
|---|---|
| All-time high | $0.1215 (Apr 10, 2024) |
| All-time low | $0.0978 (Jul 17, 2024) |
| Median price | $0.1048 |
| Average price | $0.1068 |
| Largest weekly change | -15.1% (Apr 17, 2024) |
| Weeks tracked | 119 |
| Tracking since | Aug 10, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+5.7%
5Y
N/A
All
-7.5%
Last surveyed Nov 13, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Lannett Company Inc., is $0.1068 per EA (NDC 00527241541), effective Nov 13, 2024.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 7.5%. It has been tracked across 119 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Aug 10, 2022, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0978 (Jul 17, 2024) to a high of $0.1215 (Apr 10, 2024), with a median of $0.1048 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0786 per EA — about 26% below BUPROPION HCL XL 150 MG TABLET.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 00527241541) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.